Genetron | Results Presentation Deck | 29 slides

Genetron · 2022-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide segments the market into Diagnosis & Monitoring (LDT+IVD and Biopharma Services) and Early Screening, providing specific market size estimates for eacsize_opportunity
Open slide detailBeat · Problem
04
front_matter
Open slide detailBeat · Problem
05
summarize
Open slide detailBeat · Problem
06
The slide uses a matrix-like structure to map product development stages against specific product lines.plan_implementation
07
The slide uses a matrix-like structure to map development stages against two assay strategies.plan_implementation
08
The slide outlines a personalized diagnostic process involving WES (Whole Exome Sequencing) and RACE-Seq.present_framework
09
The diagram shows a process flow from cfDNA through ligation/amplification to RACE-seq and downstream analysis (Mutation/SV).present_solution
Open slide detailBeat · Solution
10
Includes a scatter plot for assay sensitivity and two Kaplan-Meier survival curves.analyze_data
Open slide detailBeat · Solution
11
Includes Kaplan-Meier survival curves for two different cancer types, comparing personalized and fixed panels.analyze_data
Open slide detailBeat · Solution
12
Includes a scatter plot comparing Seq-MRD and FCM results, and a 2x2 contingency table for diagnostic performance.analyze_data
Open slide detailBeat · Solution
13
The slide uses a value-chain style process flow for drug development services.establish_context
Open slide detailBeat · Solution
14
Includes a table of mutation rates for 8 genes in the Chinese population and lists three key strategic commercial milestones.present_solution
Open slide detailBeat · Solution
15
front_matter
16
Includes CAGR and growth percentage annotations on charts.analyze_data
Open slide detailBeat · Financials
17
The slide outlines a dual-track strategy for hospital penetration in China, combining LDT services with IVD product sales.present_solution
Open slide detailBeat · FinancialsLoop · Voice Of Customer
18
The slide uses a combination of bar charts for gross profit (RMB million) and line charts for gross margin percentages.analyze_data
Open slide detailBeat · FinancialsLoop · Voice Of Customer
19
The slide uses a dual-axis chart style (bar for absolute value, line for percentage) to track expense trends over time.analyze_data
Open slide detailBeat · FinancialsLoop · Voice Of Customer
20
Includes a footnote regarding the definition of Non-IFRS loss and a statement on cash position.analyze_data
Open slide detailBeat · Financials
21
The slide uses two line charts to visualize the surge in cases, supporting the company's conservative financial outlook.establish_context
Open slide detailLoop · Cost Of Inaction
22
front_matter
Open slide detailLoop · Cost Of Inaction
23
Includes a timeline-style area chart for cancer management stages and a hub-and-spoke diagram for the platform ecosystem.present_solution
Open slide detailBeat · Why NowLoop · Cost Of Inaction
24
The slide uses a timeline-based visual to show how product milestones align with different stages of cancer care (Diagnosis, Surgery, Relapse, Therapy).plan_implementation
Open slide detailBeat · Why NowLoop · Quick Win Big Bet
25
The slide uses a Gantt-style chart to represent product development stages, with stars indicating NMPA approval and colored dots denoting biopsy type.plan_implementation
Open slide detailBeat · Why NowLoop · Quick Win Big Bet
26
front_matter
Open slide detailLoop · Quick Win Big Bet
27
The slide illustrates a technical workflow for ctDNA analysis including mutation and methylation detection.present_solution
28
The slide uses a visual process flow to contrast the complexity of three different sequencing workflows.compare_peers
29
front_matter